Eric Peacock
Eric Peacock
Why MyHealthTeam Became a Swoop Company and What It Means for You
Our vision has always been ambitious, but with Swoop's resources and expertise, we can achieve even more!
Eric Peacock
The Rare Disease Marketing Guide: 5 Strategies Every Pharma Marketer Needs To Know for Patient Engagement
R&D in rare diseases has skyrocketed. Thirty percent of today’s R&D pipeline is in rare diseases, and 40 percent of overall pipeline growth since 2013 is due to rare diseases.
Eric Peacock
AI, Data, and the Future of Health Care Marketing: A Conversation With 4 Pharma Advertising Experts
Health care marketing is rapidly evolving, driven by AI, health privacy legislation, the need to reach more diverse patient communities, and the growth of direct-to-patient offerings. To help us sort the reality from the hype, we invited four brilliant partners from top pharma agencies to join a panel at our recent MyHealthTeam Summer Summit in NYC. Their candid, unfiltered observations are summarized below.
Eric Peacock
The New Marketing Playbook: Engaging Patients in the Era of AI, Personalization, Patient Privacy, and Direct-to-Patient Offerings
At MyHealthTeam’s all-company get-together in Nashville, we invited five pharma marketing experts from top agencies and biotechs to join me on a panel. We discussed the “New Marketing Playbook” for everything from rare disease launches to direct-to-patient models to innovative uses of AI with patients.
Eric Peacock
Top 5 Themes From Reuters Pharma USA: A Glimpse Into the Future of Pharma Marketing
"The Reuters Pharma USA conference, held this spring in Philadelphia, is one of the best conferences attended by and featuring pharma executives. Here are our notes on some of the top themes and actionable takeaways from the event."
Eric Peacock
4 Pharma Marketing Moves to Make in 2024; Turnkey tactics to make before third-party cookies go away
As the industry faces the depreciation of third-party cookies, pharma marketers and ad agencies are looking for new ways to effectively target diagnosed patients. Here are four tactics that can be launched in-market within a matter of weeks that allow brands to engage patients where they are – patient communities.
Eric Peacock
6 Takeaways From The Future of Digital Health Panel
Digital health media is on the precipice of major change. ChatGPT and AI are advancing faster than we ever thought they would. Third-party cookies are going away slower than we ever thought they would (finally happening next year). There’s a pressing case for improving health equity and patient privacy, and the pressured budgets of pharma companies looking to hedge against an uncertain economic and regulatory future weigh heavily in 2024 marketing plans.
Eric Peacock
Online Video Ads Reached Four Times as Many Diagnosed Patients at MyHealthTeam and Here’s Why
The average person watches 17 hours of online video each week, and video ads have nine times higher recall than print. But those great results only materialize when you can effectively target your online video ads to the types of people you want to reach.
Eric Peacock
Zero Party Data Defined in 30 Seconds and Why It Matters to Health Marketers
You may have heard the phrase “zero party data,” but you’re still wondering what it means. Zero party data is information a customer intentionally and proactively shares with a company, typically with the expectation that the company will use that information to deliver some sort of personalized value to the customer.
Eric Peacock
6 Trends in Health To Bake Into Your 2023 Strategy
From zero party data and AI to cocreation with patients and proving ROI on health equity programs, there is much to be excited for in 2023. Here’s my take on six health trends to bake into your pharma marketing and medical affairs strategies.